Ligand-associated ERBB2/3 activation confers acquired resistance to FGFR inhibition in FGFR3-dependent cancer cells

Ian J Majewski, Lorenza Mittempergher, Nadia M Davidson, Astrid Bosma, Stefan M Willems, Hugo M Horlings, Iris de Rink, Liliana Greger, Gerrit KJ Hooijer, Dennis Peters, Petra M Nederlof, Ingrid Hofland, Jeroen de Jong, Jelle Wesseling, Roelof JC Kluin, Wim Brugman, Ron Kerkhoven, Frank Nieboer, Paul Roepman, Annegien Broeks, Thomas R Muley, Jacek Jassem, Jacek Niklinski, Nico van Zandwijk, Alvis Brazma, Alicia Oshlack, Michel van den Heuvel, René Bernards, Identification of recurrent FGFR3 fusion genes in lung cancer through kinome-centred RNA sequencing. The Journal of Pathology. ,vol. 230, pp. 270- 276 ,(2013) , 10.1002/PATH.4209

Robert Zeillinger, Geneviève Louason, Frank Courjal, Paul Speiser, Charles Theillet, Carmen Rodriguez, Joelle Simony-Lafontaine, Marguerite Cuny, Mapping of DNA amplifications at 15 chromosomal localizations in 1875 breast tumors: definition of phenotypic groups. Cancer Research. ,vol. 57, pp. 4360- 4367 ,(1997)

Masaru Katoh, Hitoshi Nakagama, FGF receptors: cancer biology and therapeutics. Medicinal Research Reviews. ,vol. 34, pp. 280- 300 ,(2014) , 10.1002/MED.21288

Ami Citri, Kochupurakkal Bose Skaria, Yosef Yarden, The deaf and the dumb: the biology of ErbB-2 and ErbB-3 Experimental Cell Research. ,vol. 284, pp. 54- 65 ,(2003) , 10.1016/S0014-4827(02)00101-5

V Chell, K Balmanno, A S Little, M Wilson, S Andrews, L Blockley, M Hampson, P R Gavine, S J Cook, Tumour cell responses to new fibroblast growth factor receptor tyrosine kinase inhibitors and identification of a gatekeeper mutation in FGFR3 as a mechanism of acquired resistance. Oncogene. ,vol. 32, pp. 3059- 3070 ,(2013) , 10.1038/ONC.2012.319

L. V. Sequist, B. A. Waltman, D. Dias-Santagata, S. Digumarthy, A. B. Turke, P. Fidias, K. Bergethon, A. T. Shaw, S. Gettinger, A. K. Cosper, S. Akhavanfard, R. S. Heist, J. Temel, J. G. Christensen, J. C. Wain, T. J. Lynch, K. Vernovsky, E. J. Mark, M. Lanuti, A. J. Iafrate, M. Mino-Kenudson, J. A. Engelman, Genotypic and Histological Evolution of Lung Cancers Acquiring Resistance to EGFR Inhibitors Science Translational Medicine. ,vol. 3, ,(2011) , 10.1126/SCITRANSLMED.3002003

Zhenfeng Zhang, Jae Cheol Lee, Luping Lin, Victor Olivas, Valerie Au, Thomas LaFramboise, Mohamed Abdel-Rahman, Xiaoqi Wang, Alan D Levine, Jin Kyung Rho, Yun Jung Choi, Chang-Min Choi, Sang-We Kim, Se Jin Jang, Young Soo Park, Woo Sung Kim, Dae Ho Lee, Jung-Shin Lee, Vincent A Miller, Maria Arcila, Marc Ladanyi, Philicia Moonsamy, Charles Sawyers, Titus J Boggon, Patrick C Ma, Carlota Costa, Miquel Taron, Rafael Rosell, Balazs Halmos, Trever G Bivona, Activation of the AXL kinase causes resistance to EGFR-targeted therapy in lung cancer Nature Genetics. ,vol. 44, pp. 852- 860 ,(2012) , 10.1038/NG.2330

Nicholas Turner, Richard Grose, Fibroblast growth factor signalling: from development to cancer. Nature Reviews Cancer. ,vol. 10, pp. 116- 129 ,(2010) , 10.1038/NRC2780

S F Winter, V D Acevedo, R D Gangula, K W Freeman, D M Spencer, N M Greenberg, Conditional activation of FGFR1 in the prostate epithelium induces angiogenesis with concomitant differential regulation of Ang-1 and Ang-2. Oncogene. ,vol. 26, pp. 4897- 4907 ,(2007) , 10.1038/SJ.ONC.1210288

Erez M Bublil, Yosef Yarden, The EGF receptor family: spearheading a merger of signaling and therapeutics Current Opinion in Cell Biology. ,vol. 19, pp. 124- 134 ,(2007) , 10.1016/J.CEB.2007.02.008